These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3178818

  • 21. Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection.
    Ankel H, Turriziani O, Antonelli G.
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2797-800. PubMed ID: 1940869
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of retrovirus-induced syncytium formation by photoproducts of a brominated 1,8-naphthalimide compound.
    Chanh TC, Lewis DE, Judy MM, Sogandares-Bernal F, Michalek GR, Utecht RE, Skiles H, Chang SC, Matthews JL.
    Antiviral Res; 1994 Oct; 25(2):133-46. PubMed ID: 7847875
    [Abstract] [Full Text] [Related]

  • 23. Antimitotic and antiviral activities of Kelletinin A in HTLV-1 infected MT2 cells.
    Silvestri I, Albonici L, Ciotti M, Lombardi MP, Sinibaldi P, Manzari V, Orlando P, Carretta F, Strazzullo G, Grippo P.
    Experientia; 1995 Nov 15; 51(11):1076-80. PubMed ID: 7498449
    [Abstract] [Full Text] [Related]

  • 24. Establishment of a biological assay system for human retroviral protease activity.
    Yoshida A, Piroozmand A, Sakurai A, Fujita M, Uchiyama T, Kimura T, Hayashi Y, Kiso Y, Adachi A.
    Microbes Infect; 2005 May 15; 7(5-6):820-4. PubMed ID: 15893491
    [Abstract] [Full Text] [Related]

  • 25. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
    Nakashima H, Yoshida O, Tochikura TS, Yoshida T, Mimura T, Kido Y, Motoki Y, Kaneko Y, Uryu T, Yamamoto N.
    Jpn J Cancer Res; 1987 Nov 15; 78(11):1164-8. PubMed ID: 2447045
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
    Davis DA, Branca AA, Pallenberg AJ, Marschner TM, Patt LM, Chatlynne LG, Humphrey RW, Yarchoan R, Levine RL.
    Arch Biochem Biophys; 1995 Sep 10; 322(1):127-34. PubMed ID: 7574666
    [Abstract] [Full Text] [Related]

  • 27. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.
    McGrath MS, Hwang KM, Caldwell SE, Gaston I, Luk KC, Wu P, Ng VL, Crowe S, Daniels J, Marsh J.
    Proc Natl Acad Sci U S A; 1989 Apr 10; 86(8):2844-8. PubMed ID: 2704750
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M, Fikkert V, Pluymers W, Matthews B, Mardel K, Schols D, Raff J, Debyser Z, De Clercq E, Holan G, Pannecouque C.
    Mol Pharmacol; 2000 Nov 10; 58(5):1100-8. PubMed ID: 11040059
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N, Schols D, De Clercq E, Debyser Z, Pauwels R, Balzarini J, Nakashima H, Baba M, Hosoya M, Snoeck R.
    Mol Pharmacol; 1992 Dec 10; 42(6):1109-17. PubMed ID: 1282664
    [Abstract] [Full Text] [Related]

  • 31. Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro.
    Ito M, Baba M, Sato A, Hirabayashi K, Tanabe F, Shigeta S, De Clercq E.
    Biochem Biophys Res Commun; 1989 Jan 16; 158(1):307-12. PubMed ID: 2912452
    [Abstract] [Full Text] [Related]

  • 32. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H.
    Proc Natl Acad Sci U S A; 1986 Nov 16; 83(21):8333-7. PubMed ID: 2430286
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.
    Sarin PS, Sun D, Thornton A, Müller WE.
    J Natl Cancer Inst; 1987 Apr 16; 78(4):663-6. PubMed ID: 2435942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.